Ben Zealley, MSc

Ben Zealley, MSc is Director of Web Services and Content at the Longevity Escape Velocity (LEV) Foundation, whose interest lies in the biology of human aging and in developing interventions that substantially reverse that process, hence extending healthy lifespans.

He is particularly interested in technologies with a short lead time before marketability, as he sees them as critical to creating a true rejuvenation medicine industry.

His specialties include rejuvenation, anti-aging, stem cells, gene therapy, transplantation, tolerance, immunosenescence, allotopic expression, and bioengineering.

Ben has been the Director of Web Services & Content at LEV Foundation since 2022. The Foundation is conducting and inspiring research to comprehensively cure and prevent human age-related diseases.

Ben has also been a Researcher at the SENS Foundation since 2009. He is Research Assistant to Dr. Aubrey de Grey, where his responsibilities include literature awareness, research planning, technical outreach, and web administration.

He was the Assistant Editor of the SENS Foundation’s journal, Rejuvenation Research. Previously, he was helping Aubrey as Researcher at Methuselah Foundation, between 2007 and 2009.

Ben earned his Master’s Degree of Science in Biochemistry in 2007 from the University of Cambridge, where he was also the President of the Cambridge University Life Extension and Rejuvenation Society.

Ben is a Member of the Live Forever Club and is among 40 Personalities of 2000 Longevity Leaders: Longevity Legends.

Read Cancers Co-opt Cohabitants’ Catabolism, Whole-Animal Senescent Cytotoxic T Cell Removal Using Antibodies Linked to Magnetic Nanoparticles, Strategies for Engineered Negligible Senescence, and Direct interaction between centralspindlin and PRC1 reinforces mechanical resilience of the central spindle.

Visit his LinkedIn profile and his ResearchGate profile. Follow him on Facebook, Godseed Blog, and YouTube.